317 related articles for article (PubMed ID: 26842920)
21. Growth hormone receptor (GHR) gene polymorphism and scoliosis in Prader-Willi syndrome.
Butler MG; Hossain W; Hassan M; Manzardo AM
Growth Horm IGF Res; 2018 Apr; 39():29-33. PubMed ID: 29273483
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
Lindgren AC; Lindberg A
Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous growth in German children and adolescents with genetically confirmed Prader-Willi syndrome.
Hauffa BP; Schlippe G; Roos M; Gillessen-Kaesbach G; Gasser T
Acta Paediatr; 2000 Nov; 89(11):1302-11. PubMed ID: 11106040
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.
Reus L; Pelzer BJ; Otten BJ; Siemensma EP; van Alfen-van der Velden JA; Festen DA; Hokken-Koelega AC; Nijhuis-van der Sanden MW
Res Dev Disabil; 2013 Oct; 34(10):3092-103. PubMed ID: 23886754
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
Cohen M; Harrington J; Narang I; Hamilton J
Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone, gender and face shape in Prader-Willi syndrome.
de Souza MA; McAllister C; Suttie M; Perrotta C; Mattina T; Faravelli F; Forzano F; Holland A; Hammond P
Am J Med Genet A; 2013 Oct; 161A(10):2453-63. PubMed ID: 23918156
[TBL] [Abstract][Full Text] [Related]
28. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
29. Development and implementation of electronic growth charts for infants with Prader-Willi syndrome.
Rosenbloom ST; Butler MG
Am J Med Genet A; 2012 Nov; 158A(11):2743-9. PubMed ID: 22903930
[TBL] [Abstract][Full Text] [Related]
30. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
[TBL] [Abstract][Full Text] [Related]
33. Beneficial Effects of Long-Term Growth Hormone Treatment on Adaptive Functioning in Infants With Prader-Willi Syndrome.
Lo ST; Festen DA; Tummers-de Lind van Wijngaarden RF; Collin PJ; Hokken-Koelega AC
Am J Intellect Dev Disabil; 2015 Jul; 120(4):315-27. PubMed ID: 26161469
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
[TBL] [Abstract][Full Text] [Related]
35. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
Jin YY; Luo FH
Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
[TBL] [Abstract][Full Text] [Related]
36. Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.
Dudley O; McManus B; Vogels A; Whittington J; Muscatelli F
J Intellect Disabil Res; 2008 May; 52(Pt 5):426-36. PubMed ID: 18298478
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
38. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
39. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency.
Thacker MJ; Hainline B; St Dennis-Feezle L; Johnson NB; Pescovitz OH
Horm Res; 1998; 49(5):216-20. PubMed ID: 9568805
[TBL] [Abstract][Full Text] [Related]
40. Prader-Willi syndrome, diabetes mellitus and hypogonadism.
Nagai T; Mori M
Biomed Pharmacother; 1999 Dec; 53(10):452-4. PubMed ID: 10665337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
